Abstract:
The present disclosure provides methods and compositions for performing nucleic acid reactions, such as the reverse transcriptase-polymerase chain reaction (RT-PCR).
Abstract:
Methods and compositions for detecting and quantifying polynucleotide in a sample. Specifically, methylated DNA is quantified to determine the load ofpolynucleotides in a sample. Non-invasive methods for determining the load of fetal polynucleotides in maternal plasma. Methods and compositions for detecting cellular processes such as cellular viability, growth rates, and infection rates. Methods for detecting differences in copy number of a target polynucleotide, specifically, for diagnosis of fetal genetic abnormalities, when the starting sample is maternal blood, serum, or plasma.
Abstract:
The present disclosure provides methods and compositions for performing nucleic acid reactions, such as the reverse transcriptase-polymerase chain reaction (RT-PCR).
Abstract:
The present disclosure provides methods and compositions for detecting polynucleotides in a sample and for quantifying polynucleotide load in a sample. The polynucleotides can be associated with a disease, disorder, or condition. In some applications, methylated DNA is quantified, e.g., in order to determine the load of polynucleotides in a sample. The present disclosure also provides methods and compositions for determining the load of fetal polynucleotides in a biological sample, e.g., the load of fetal polynucleotides (e.g., DNA, RNA) in maternal plasma. The present disclosure provides methods and compositions for detecting cellular processes such as cellular viability, growth rates, and infection rates. This disclosure also provides compositions and methods for detecting differences in copy number of a target polynucleotide. In some embodiments, the methods and compositions provided herein are useful for diagnosis of fetal genetic abnormalities, when the starting sample is maternal tissue (e.g., blood, plasma).